An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial-an update to the published protocol.
Trials
; 25(1): 457, 2024 Jul 05.
Article
en En
| MEDLINE
| ID: mdl-38970065
ABSTRACT
This article reports an update to the protocol of the IMASOY trial, which was prospectively registered on clinicaltrials.gov (NCT04110340) in October 2019.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Ciprofloxacina
/
Antibacterianos
Límite:
Animals
/
Humans
Idioma:
En
Año:
2024
Tipo del documento:
Article